Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder.

Şimşek Ş, Gençoğlan S, Yüksel T, Kaplan İ, Alaca R.

J Clin Psychiatry. 2016 Jul;77(7):e855-9. doi: 10.4088/JCP.15m10146.

PMID:
27314567
2.

Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder.

Kluge M, Schüssler P, Künzel HE, Dresler M, Yassouridis A, Steiger A.

J Psychiatr Res. 2007 Dec;41(11):928-33. Epub 2006 Oct 17.

PMID:
17049559
3.

Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Çolak Sivri R, Bilgiç A, Kılınç İ.

Eur Child Adolesc Psychiatry. 2018 Aug;27(8):977-984. doi: 10.1007/s00787-017-1099-3. Epub 2018 Jan 4.

PMID:
29302747
4.

Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.

Kawano A, Tanaka Y, Ishitobi Y, Maruyama Y, Ando T, Inoue A, Okamoto S, Imanaga J, Kanehisa M, Higuma H, Ninomiya T, Tsuru J, Akiyoshi J.

Psychiatry Res. 2013 Aug 30;209(1):85-90. doi: 10.1016/j.psychres.2012.11.010. Epub 2012 Dec 23.

PMID:
23266021
5.

Neurotrophic factors in obsessive-compulsive disorder.

Fontenelle LF, Barbosa IG, Luna JV, Rocha NP, Silva Miranda A, Teixeira AL.

Psychiatry Res. 2012 Oct 30;199(3):195-200. doi: 10.1016/j.psychres.2012.03.034. Epub 2012 Apr 9.

PMID:
22494702
6.

BDNF and cortisol levels in children with or without post-traumatic stress disorder after sustaining sexual abuse.

Simsek S, Uysal C, Kaplan I, Yuksel T, Aktas H.

Psychoneuroendocrinology. 2015 Jun;56:45-51. doi: 10.1016/j.psyneuen.2015.02.017. Epub 2015 Mar 10.

PMID:
25800148
7.

Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study.

Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L.

J Affect Disord. 2010 Apr;122(1-2):174-8. doi: 10.1016/j.jad.2009.07.009. Epub 2009 Aug 6.

8.

BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.

Wang Y, Zhang H, Li Y, Wang Z, Fan Q, Yu S, Lin Z, Xiao Z.

J Affect Disord. 2015 Nov 1;186:7-12. doi: 10.1016/j.jad.2015.07.023. Epub 2015 Jul 14.

PMID:
26209750
9.

The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).

Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P.

Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 5;150B(8):1050-62. doi: 10.1002/ajmg.b.30930.

PMID:
19219856
10.

Vitamin D levels in children and adolescents with obsessive compulsive disorder.

Yazici KU, Percinel Yazici I, Ustundag B.

Nord J Psychiatry. 2018 Apr;72(3):173-178. doi: 10.1080/08039488.2017.1406985. Epub 2017 Nov 23.

PMID:
29168423
11.

Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients.

Wang Y, Mathews CA, Li Y, Lin Z, Xiao Z.

J Affect Disord. 2011 Sep;133(1-2):305-10. doi: 10.1016/j.jad.2011.04.002. Epub 2011 May 25.

PMID:
21616543
12.

Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders.

Tunca Z, Kıvırcık Akdede B, Özerdem A, Alkın T, Polat S, Ceylan D, Bayın M, Cengizçetin Kocuk N, Şimşek S, Resmi H, Akan P.

Eur Psychiatry. 2015 Feb;30(2):198-204. doi: 10.1016/j.eurpsy.2014.11.003. Epub 2014 Dec 24.

PMID:
25543333
13.

Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.

Gallant J, Storch EA, Merlo LJ, Ricketts ED, Geffken GR, Goodman WK, Murphy TK.

J Anxiety Disord. 2008 Dec;22(8):1369-76. doi: 10.1016/j.janxdis.2008.01.017. Epub 2008 Feb 7.

PMID:
18329843
14.

Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.

Anagnostopoulos DC, Korlou S, Sakellariou K, Kondyli V, Sarafidou J, Tsakanikos E, Giannakopoulos G, Liakopoulou M.

Psychiatriki. 2016 Jan-Mar;27(1):27-36.

PMID:
27110880
15.

Obsessive-compulsive traits in children and adolescents with Asperger syndrome.

Ruta L, Mugno D, D'Arrigo VG, Vitiello B, Mazzone L.

Eur Child Adolesc Psychiatry. 2010 Jan;19(1):17-24. doi: 10.1007/s00787-009-0035-6. Epub 2009 Jun 26.

PMID:
19557496
16.

The relationship between Toxoplasma gondii IgG antibodies and generalized anxiety disorder and obsessive-compulsive disorder in children and adolescents: a new approach.

Akaltun İ, Kara SS, Kara T.

Nord J Psychiatry. 2018 Jan;72(1):57-62. doi: 10.1080/08039488.2017.1385850. Epub 2017 Oct 9.

PMID:
28990850
17.
18.

Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.

Şimşek Ş, Gençoğlan S, Yüksel T, Kaplan İ, Aktaş H.

J Clin Psychopharmacol. 2015 Oct;35(5):596-9. doi: 10.1097/JCP.0000000000000378.

PMID:
26267416
19.

Serum Cytokine Profiles of Children with Obsessive-Compulsive Disorder Shows the Evidence of Autoimmunity.

Şimşek Ş, Yüksel T, Çim A, Kaya S.

Int J Neuropsychopharmacol. 2016 Aug 12;19(8). pii: pyw027. doi: 10.1093/ijnp/pyw027. Print 2016 Aug.

20.

The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.

Tükel R, Ozata B, Oztürk N, Ertekin BA, Ertekin E, Direskeneli GS.

J Clin Neurosci. 2014 May;21(5):790-3. doi: 10.1016/j.jocn.2013.07.037. Epub 2013 Oct 11.

PMID:
24291483

Supplemental Content

Support Center